Investor Relations

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy, but altering their delivery profile using the Company’s proprietary transdermal delivery system. The Company’s goal is to make transdermal drug delivery a standard of care for delivering drugs requiring fast onset of action.

NASDAQ: ZSAN
4.30
- 0.01 (-0.12%)
Day High: 4.50
Day Low:  4.05
Volume:    41,801
3:59 PM ET on Feb 16, 2018

Delayed at least 20 minutes.